Sen. Bernie Sanders, a Democratic presidential candidate from Vermont, and Rep. Elijah Cummings of Maryland, have asked Shkreli and Turing to reconsider their actions.
Martin Shkreli, a former hedge fund manager who is now chief executive officer of Turing Pharmaceuticals AG, was called out by Democratic presidential candidate Hillary Clinton.
But the price hike sparked outrage from medical groups representing doctors who care for patients with HIV and other infectious diseases, because Daraprim treats patients with compromised immune systems.